Anika Therapeutics Inc. Overview
Company Headquarters: Massachusetts, US
Founded: 1992
Workforce: ~133
Company Working: Anika Therapeutics is an orthopedic and regenerative medicines company. Its offers products based on hyaluronic acid, biocompatible polymer, and natural chemical. In the US, the company owns 19 patents and internationally 187 patents. In 2018, the company’s top five customers account 86% of the revenue, e.g., Mitek, a part of Johnson & Johnson medical device company and the global leader in orthopedic sports medicine accounted 73% of the company sales revenue. The company primarily depends on a small number of large customers, particularly Mitek, for the majority of its sales revenues. The company markets and distribute its products in the US, Italy, and European countries, among others.
Strategy
Anika Therapeutics Inc. strongly emphasizes the continuous launch of products and has a wide range of products in its clinical pipeline. For the success of these products, the company invests in sales and marketing. Moreover, it focuses on maximizing the growth of its core product segments. It also aims at optimizing the growth of core product segments.
